Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral methylene blue for symptom control and quality of life in end-stage metastatic breast cancer
IRCT20191228045924N10Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methylene blue in breast cancer, sponsored by Mashhad University of Medical Sciences. Primary endpoints: Pain control, Quality of life and 2 more. Started Feb 2026; status: completed.
02
Drugs
methylene blue
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20191228045924N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191228045924N10.